A Phase 1/2 Dose Escalation and Dose Expansion Study of ZNc3 in Combination with Niraparib in Subjects with Platinum Resistant Ovarian Cancer

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Setsuko Chambers
Sponsor
GOG Foundation, Inc.
Unit
Cancer Center Division